Advancing Biomedical Science

The Laboratory for Clinical Biochemistry Research (LCBR) focuses on understanding risk factors for heart disease, stroke, venous thrombosis, obesity, diabetes, aging, and frailty using a wide variety of assays in population and family-based research settings, particularly in the areas of coagulation, fibrinolysis, thrombosis, inflammation, and immune system function. These results are linked to animal model studies, especially research in murine atherosclerosis

Image of the Colchester Research Facility

Clinical Studies

The Laboratory research portfolio includes molecular and genetic epidemiology family-based genetic research, clinical trials and basic studies using murine models of disease.

Dr. Olson removing samples from one of the LCBR freezers.

Technical Information

The LCBR Faculty and staff has accumulated a vast amount and diverse range of experience working with and developing multitudes of clinical assays, including information regarding Luminex Overview, and Luminex Data by Analyte.

Drs. Cushman and Zakai discussing research


The Laboratory staff have collaborated on a wide variety of clinical studies, clinical trials, and epidemiology studies on local, national, and international scales.

Faculty Spotlight


Cushman & Page Receive Accolades at the AHA 2018 Scientific Sessions

The American Heart Association (AHA) awarded its Population Research Prize to Mary Cushman, M.D., professor of medicine at the Larner College of Medicine at the University of Vermont, during the opening ceremonies at the AHA Scientific Sessions 2018 at McCormick Place convention center in Chicago on November 11. In addition, UVM Larner College of Medicine Dean Richard L. Page, M.D., was honored with the Council on Clinical Cardiology (CLDC) Distinguished Achievement Award at the Council’s Annual Business Meeting and Dinner on November 10, 2018.